C5's UPC Institute
Refining Life Sciences IP Litigation Strategies After the UPC’s Inaugural Year
Stefania Bergia
Partner
Simmons & Simmons LLP
Christoph de Coster
Partner
Taylor Wessing
Oliver Jan Jüngst
Partner
Bird & Bird
Dr. Ulrich Blumenröder
Partner
Grünecker Patent
- Evaluating and refining litigation strategies to leverage the experiences and precedents set in the first year of the UPC
- Understanding how initial rulings and procedural nuances have shaped the litigation landscape
- Tailoring offensive and defensive strategies in the UPC context, incorporating lessons learned from the court’s inaugural year
- Understanding which arguments and approaches have proven most effective in this new legal environment
- Understanding which arguments and approaches have proven most effective in this new legal environment
- Analyzing the evolving relationship between EPO opposition proceedings and validity challenges within the UPC
- Assessing how decisions in one forum influence strategies and outcomes in the other